GORDON CARL L 4
4 · Compass Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
GORDON CARL L
Director
Transactions
- Award
Stock Option (Right to Buy)
2026-01-02+90,000→ 90,000 totalExercise: $5.17Exp: 2036-01-02→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]This grant vests in full upon the earlier of (i) June 10, 2026 or (ii) the date of the next annual meeting of the Company's stockholders.
- [F2]The Reporting Person is a member of OrbiMed Advisors LLC ("OrbiMed Advisors"). Pursuant to an agreement with OrbiMed Advisors, the Reporting Person is obligated to transfer any securities issued under any stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors and OrbiMed Capital GP V LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments V-KA, LP.